Toggle navigation
Home
Search
Services
Blog
Contact
About
Mediated Antifolate Resistance in Mammalian Cells
Melera, Peter W.
University of Maryland Baltimore, Baltimore, MD, United States
Search 28 grants from Peter Melera
Search grants from University of Maryland Baltimore
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Project 1: Induction of Tolerance to Heart Allograft in Nonhuman Primates by Donor Kidney Co-Transplantation
Georgia Pregnancy Risk Assessment Monitoring System
Clinical Center for Camp-N01HR1604-268016044
Core - Biostatistics and data management
Fatty Acid Composition on Ganglioside Expression in Nervous System
Recently added grants:
Exploring the Innate Sensors Underlying Cancer Immunosurveillance
Background free amplified single-molecule FISH for in situ and flow cytometric applications
Using [6-13C,6-15N3]-L-Arginine for the molecular imaging of in vivo tumor arginase flux, and towards understanding the role of arginase isoforms in cancer metabolism.
Chromatin Organization Regulates Osteogenesis
Novel genetics, pathobiology and therapy of nephronophthisis-related ciliopathies
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Biomedical Research Support Grants (S07)
Project #
2S07RR005379-29
Application #
3889316
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
29
Fiscal Year
1990
Total Cost
Indirect Cost
Institution
Name
University of Maryland Baltimore
Department
Type
DUNS #
003255213
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Related projects
Publications
Hudson, G M; Marquis, K L; Stamidis, H et al.
(1992)
Cholecystokinin octapeptide alters morphine-induced effects on EEG power spectra both quantitatively and qualitatively.
Eur J Pharmacol 221:217-22
Comments
Be the first to comment on Peter Melera's grant